- AU$19.00m
- AU$9.94m
- AU$0.43m
Australia Stock Exchange release from INOVIQ : Update on Legal Proceedings and BARD1 Autoantibody Program
Australia Stock Exchange release from INOVIQ : Appendix 4D and Half Year Financial Report
Australia Stock Exchange release from INOVIQ : PRE_NR Ends: 11:42:02
Australia's Inoviq sees best day in 2 weeks on Brazil patent
Australia Stock Exchange release from INOVIQ : Brazilian Patent Issued for Lung & Colorectal Cancer
Australia Stock Exchange release from INOVIQ : PRE_NR Ends: 10:34:58
Australia Stock Exchange release from INOVIQ : Updated Investor Presentation
Australia Stock Exchange release from INOVIQ : Notification regarding unquoted securities - IIQ
Australia Stock Exchange release from INOVIQ : PRE_NR Ends: 10:24:46
Australia Stock Exchange release from INOVIQ : Appendix 4C & Quarterly Activities Report
Australia Stock Exchange release from INOVIQ : US Patent Issued - BARD1 Breast & Ovarian Cancer Diagnosis
Australia Stock Exchange release from INOVIQ : INOVIQ Awarded Additional BTB Funding to Develop SubB2M test
Australia Stock Exchange release from INOVIQ : INOVIQ Appendix 4G and Corporate Governance Statement
Australia's Inoviq rises on Chinese patent for lung cancer test
Australia Stock Exchange release from INOVIQ : Appendix 3Y - Change of Director's Interest Notice x 4
Australia Stock Exchange release from INOVIQ : Notification regarding unquoted securities - IIQ
Australia Stock Exchange release from BARD1 LIFE SCI : BARD1 Changes its Name to INOVIQ
Australia Stock Exchange release from BARD1 LIFE SCI : Application for quotation of securities - BD1
Australia Stock Exchange release from BARD1 LIFE SCI : Cleansing Notice - Issued of Four Shares - Resolution 5 AGM